Bioventix PLC (LSE:BVXP) - Share price - Overview

Stock Report

Bioventix PLC BVXP

Last Price
GBX2,717.00

Day Change
67.00|2.53%

As of 17/11/2017
17:53:48 GMT | GBX
Minimum 15 Minutes Delay.

Last Close2,650.00p
Day Range2,650.00 - 2,750.00
Mkt Cap-
52-Wk Range26.00 - 2,950.00
Yield %1.69
ISINGB00B4QVDF07
Volume3,821
P/E28.84
P/S24.88
P/CF42.37

Share Price

Total Returns 17/11/2017

 Chg (%)  
More ...
Bioventix PLC4.71 
FTSE 100 TR GBP-1.44
 
Financials
201520162017
More ...
Income Statement
Turnover4.335.52-
Operating Profit3.104.21-
Net Profit2.563.50-
Reported EPS49.7967.95-
Balance Sheet
Current Assets6.428.27-
Non Current Assets0.490.51-
Total Assets6.908.78-
Current Liabilities0.300.55-
Total Liabilities0.320.57-
Total Equity6.588.21-
Cash Flow
Operating Cash Flow2.913.72-
Net Change in Cash0.781.25-
Broker Forecasts
Year EndingPre-taxEPSEPSgP/EPEGDPSYld %
More ...
'Broker Forecasts' provides consensus figures based on several brokers' views
20185.4085.90-8.83--61.00-
20196.2098.5014.67--73.00-
Director Dealings
TradedActionNotifierPriceAmountValue
More ...
19/10/2017SaleMr. Ian Nicholson2,400.752,50060,019.00
19/10/2017SaleMr. Ian Nicholson2,400.752,50060,019.00
19/10/2017SaleMr. Peter Harrison2,425.0080,0001,940,000.00

Company Profile

Bioventix PLC is engaged in the field of biotechnology. Its business involves the development of high-affinity sheep monoclonal antibodies and clinical diagnostics and drugs of abuse testing.

Sector

Biotechnology

Market Position

of Companies

Index

FTSE AIM All Share

Outlook

(16/10/2017) no outlook statement

Next Event 14/12/2017

Next AGM
Ratios
CompSecMkt
More ...
PER (E)0.0013.6316.14
Div Yld (E)0.004.134.26
PEG (E)0.001.241.34
ROCE0.00180.3415.81
Op Mrgn0.00-8.42-9.53
EPS Grwth0.0012.8214.73
Dividends
PreviousLatest
More ...
Record Date27/10/1727/10/17
Ex-Div26/10/1726/10/17
Paid10/11/1710/11/17
Amnt40.0031.00

Broker Sentiment

Strong Buy0
Buy0
Hold0
Sell0
Strong Sell0
  • Strong Sell
  • Strong Buy
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
More ...
Disclaimer
Directors
More ...
ChairmanMr. Ian Nicholson
Chief Executive OfficerMr. Peter Harrison
Finance DirectorTreena Turner
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2017 Morningstar. All rights reserved.